What is the price target for CRMD stock?
13 analysts have analysed CRMD and the average price target is 14.86 USD. This implies a price increase of 98.7% is expected in the next year compared to the current price of 7.48.
CORMEDIX INC (CRMD) Forecast, Price Target & Analyst Ratings
NASDAQ:CRMD • US21900C3088
Current stock price
7.48 USD
-0.09 (-1.19%)
At close:
7.46 USD
-0.02 (-0.27%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORMEDIX INC (CRMD).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.42
- Revenue Estimate
- 106.64M
Price Target Details & History
Consensus Price Target and Range
Mean target
$14.86
Upside
+ 98.70%
From current price of $7.48 to mean target of $14.86, Based on 13 analyst forecasts
Low
$13.13
Median
$14.28
High
$19.95
Price Target Revisions
1 Month
-1.92%
3 Months
-13.56%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for CRMD. The average price target is 14.86 USD. This implies a price increase of 98.7% is expected in the next year compared to the current price of 7.48.
The average price target has been revised downward by 13.56% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.08%
CRMD was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRMD.
In the previous month the buy percentage consensus was at a similar level.
CRMD was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-28 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2026-04-28 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2026-04-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-04-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-04-27 | Needham | Maintains | Buy -> Buy |
| 2026-03-05 | Needham | Maintains | Buy -> Buy |
| 2026-02-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-08 | Needham | Maintains | Buy -> Buy |
| 2025-12-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-12 | Needham | Maintains | Buy -> Buy |
| 2025-10-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | D. Boral Capital | Upgrade | Hold -> Buy |
| 2025-09-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-30 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-06-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-06-24 | Needham | Maintains | Buy -> Buy |
| 2025-06-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.42
- Revenue Estimate
- 106.64M
- Revenue Q2Q
- 172.86%
- EPS Q2Q
- 41.49%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
0.13%
Revenue (3 Months)
0.21%
EPS (1 Month)
-11.30%
EPS (3 Months)
-32.36%
Next Earnings Summary
CRMD is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.42 USD and the consensus revenue estimate is 106.64M USD.
The next earnings revenue estimate has been revised upward by 0.21% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 43.472M | 311.709M 617.03% | 312.65M 0.30% | 295.89M -5.36% | 355.11M 20.01% | 433.02M 21.94% | 571.53M 31.99% | 720.35M 26.04% | 808.37M 12.22% | 936.88M 15.90% | |
| EBITDA YoY % growth | -48.887M -60.08% | -22.047M 54.90% | 164.69M 847.01% | 122.56M -25.58% | 107.34M -12.42% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -48.958M -59.89% | -22.356M 54.34% | 150.141M 771.58% | 91.795M -38.86% | 75.38M -17.88% | 116.63M 54.72% | 158.97M 36.30% | 274.6M 72.74% | 441.07M 60.62% | 522.29M 18.41% | 627.03M 20.05% | |
| Operating Margin | N/A | -51.43% | 48.17% | 29.36% | 25.48% | 32.84% | 36.71% | 48.05% | 61.23% | 64.61% | 66.93% | |
| EPS YoY % growth | -0.92 -24.32% | -0.33 64.13% | 2.02 712.12% | 0.85 -58.05% | 0.69 -18.88% | 0.93 34.63% | 1.80 94.00% | 3.64 102.84% | 4.19 15.13% | 4.67 11.44% | 5.34 14.41% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.42 41.49% | 0.35 24.84% | -0.01 -101.10% | -0.03 -117.00% | 0.11 -73.57% | 0.10 -70.82% | 0.07 615.84% | 0.08 366.67% |
| Revenue Q2Q % growth | 106.64M 172.86% | 97.143M 144.47% | 54.86M -47.39% | 54.582M -57.56% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 55.77M 174.90% | 44.802M 125.49% | 11.339M -79.56% | 10.654M -85.54% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 49.877M 147.83% | 36.6M 87.27% | 1.309M -97.45% | -986.34K -101.67% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-22.91%
EPS Next 5 Year
12.51%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.93%
Revenue Next 5 Year
12.56%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CORMEDIX INC / CRMD Forecast FAQ
Can you provide the upcoming earnings date for CORMEDIX INC?
CORMEDIX INC (CRMD) will report earnings on 2026-05-07.
What are the consensus estimates for CRMD stock next earnings?
The consensus EPS estimate for the next earnings of CORMEDIX INC (CRMD) is 0.42 USD and the consensus revenue estimate is 106.64M USD.
What is the consensus rating for CRMD stock?
The consensus rating for CORMEDIX INC (CRMD) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.